Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00538512 · ClinicalTrials.gov registry record · Phase 4
Comparative Study of Influenza Vaccines in Adults, FLUVACS-year 4
A Phase 4 study, sponsored by University of Michigan.
- Completed
- Registry status
- Phase 4
- Development phase
- 1,952
- Enrollment target
NCT00538512 is a Phase 4 study that has completed, run by University of Michigan. The registered enrollment target is 1,952 participants.
The verdict
NCT00538512, a Phase 4 study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1,952 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the absolute (versus placebo) and relative (one vaccine compared to the other) efficacies of the live attenuated and inactivated influenza vaccines in preventing laboratory confirmed symptomatic influenza caused by circulating strains whether similar or dissimilar to strains included in the vaccines.
Interventions
- BIOLOGICAL Fluzone
- OTHER Physiologic saline
- BIOLOGICAL Flumist
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,952 participants |
| Start Date | 2007-09 |
| Est. Completion | 2008-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00538512
The ClinicalTrials.gov registry entry for NCT00538512 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 1,952 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Fluzone is the first listed.
NCT00538512 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00538512 about?
NCT00538512 is a clinical study titled "Comparative Study of Influenza Vaccines in Adults, FLUVACS-year 4". The purpose of this study is to evaluate the absolute (versus placebo) and relative (one vaccine compared to the other) efficacies of the live attenuated and inactivated influenza vaccines in preventing laboratory confirmed symptomatic influenza caused by circulating strains whether similar or dissi...
What is the current status of trial NCT00538512?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,952 participants. The study started on 2007-09. Estimated completion is 2008-05.
What interventions are being tested in trial NCT00538512?
The interventions under investigation include: Fluzone (BIOLOGICAL), Physiologic saline (OTHER), Flumist (BIOLOGICAL).
Who is sponsoring clinical trial NCT00538512?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.